secwatch.observer — SEC 8-K summary
======================================

Issuer:     Definitive Healthcare Corp. (DH)
CIK:        0001861795
Form:       8-K
Filed at:   2023-08-01T23:59:59+00:00
Accession:  0000950170-23-036178
Event type: other_material
Sentiment:  negative
Materiality: 0.85
Item codes: 2.02, 2.05, 4.02, 7.01, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Definitive Healthcare restates prior financials due to sales tax error; Q2 rev $61M, cuts 4% workforce
--------------------------------------------------------------------------------

- Restates 2020-2022 and Q1 2023 financials over sales tax; expects G&A expense increase of $6.8M-$10.2M.
- Preliminary Q2 revenue $61M, net loss $11.4-11.8M, adj. EBITDA $17.2M; reaffirms FY revenue $249-255M and adj. EBITDA $67-71M.
- Cuts 42 jobs (~4% workforce); expects pre-tax restructuring charges of $1.8M-$2.0M in Q3 2023.
- Material weakness in internal control over financial reporting identified; Q2 2023 earnings call moved to Aug 14.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1861795/000095017023036178/0000950170-23-036178-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1861795/000095017023036178/dh-20230727.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-036178

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer